心肌细胞
移植
心室
生物
心肌梗塞
内科学
肿瘤抑制因子
细胞生物学
心脏病学
细胞因子
免疫学
白细胞介素6
医学
作者
Henning Ebelt,M Jungblut,Ying Zhang,Thomas Kubin,Sawa Kostin,Antje Technau,Svetlana Oustanina,Sylvia Niebruegge,Jürgen Lehmann,Karl Werdan,Thomas W Braun
出处
期刊:Stem Cells
[Oxford University Press]
日期:2006-09-14
卷期号:25 (1): 236-244
被引量:119
标识
DOI:10.1634/stemcells.2006-0374
摘要
A growing number of studies are reporting beneficial effects of the transplantation of alleged cardiac stem cells into diseased hearts after myocardial infarction. However, the mechanisms by which transplanted cells might help to promote repair of cardiac tissue are not understood and might involve processes different from the differentiation of transplanted cells into cardiomyocytes. We have compared the effects exerted by skeletal myoblasts (which are not able to form new cardiomyocytes) and ESC-derived cardiomyocytes after implantation into infarcted mouse hearts by echocardiographic follow-up and histological analysis and related these effects to the release of cardioactive cytokines. We found that both cell types led to a long-lasting improvement of left ventricle function and to an improvement of tissue architecture. Since no relevant amounts of myoblast-derived cells were present in infarcted hearts 28 days after transplantation, we investigated the release of cytokines from implanted cells both before and after transplantation into infarcted hearts. ESC-derived cardiomyocytes and myoblasts secreted substantial amounts of interleukin (IL)-1alpha, IL-6, tumor necrosis factor-beta, and oncostatin M, which strongly supported survival and protein synthesis of cultured cardiomyocytes. We postulate that the beneficial effects of the transplantation of myoblasts and cardiomyocytes on heart function and morphology only partially (if at all) depend on the integration of transplanted cells into the myocardium but do depend on the release of a complex blend of cardioactive cytokines.
科研通智能强力驱动
Strongly Powered by AbleSci AI